These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 37591406)

  • 41. Hepatic Overexpression of Soluble Urokinase Receptor (uPAR) Suppresses Diet-Induced Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient (LDLR-/-) Mice.
    Larmann J; Jurk K; Janssen H; Müller M; Herzog C; Lorenz A; Schmitz M; Nofer JR; Theilmeier G
    PLoS One; 2015; 10(8):e0131854. PubMed ID: 26313756
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Insulin-degrading enzyme deficiency in bone marrow cells increases atherosclerosis in LDL receptor-deficient mice.
    Caravaggio JW; Hasu M; MacLaren R; Thabet M; Raizman JE; Veinot JP; Marcel YL; Milne RW; Whitman SC
    Cardiovasc Pathol; 2013; 22(6):458-64. PubMed ID: 23684818
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Low carbohydrate, high protein diet promotes atherosclerosis in apolipoprotein E/low-density lipoprotein receptor double knockout mice (apoE/LDLR(-/-)).
    Kostogrys RB; Franczyk-Żarów M; Maślak E; Gajda M; Mateuszuk L; Jackson CL; Chłopicki S
    Atherosclerosis; 2012 Aug; 223(2):327-31. PubMed ID: 22771189
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Aortic cholesterol accumulation correlates with systemic inflammation but not hepatic and gonadal adipose tissue inflammation in low-density lipoprotein receptor null mice.
    Wang S; Miller B; Matthan NR; Goktas Z; Wu D; Reed DB; Yin X; Grammas P; Moustaid-Moussa N; Shen CL; Lichtenstein AH
    Nutr Res; 2013 Dec; 33(12):1072-82. PubMed ID: 24267047
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Heparin-binding EGF-like growth factor (HB-EGF) antisense oligonucleotide protected against hyperlipidemia-associated atherosclerosis.
    Kim S; Graham MJ; Lee RG; Yang L; Kim S; Subramanian V; Layne JD; Cai L; Temel RE; Shih D; Lusis AJ; Berliner JA; Lee S
    Nutr Metab Cardiovasc Dis; 2019 Mar; 29(3):306-315. PubMed ID: 30738642
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dysfunction of lipid metabolism in lipodystrophic Seipin-deficient mice.
    Wang M; Gao M; Liao J; Han Y; Wang Y; Liu G
    Biochem Biophys Res Commun; 2015 May; 461(2):206-10. PubMed ID: 25866184
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Addition of dietary fat to cholesterol in the diets of LDL receptor knockout mice: effects on plasma insulin, lipoproteins, and atherosclerosis.
    Wu L; Vikramadithyan R; Yu S; Pau C; Hu Y; Goldberg IJ; Dansky HM
    J Lipid Res; 2006 Oct; 47(10):2215-22. PubMed ID: 16840797
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of vitamin E on oxidative stress and atherosclerosis in an obese hyperlipidemic mouse model.
    Hasty AH; Gruen ML; Terry ES; Surmi BK; Atkinson RD; Gao L; Morrow JD
    J Nutr Biochem; 2007 Feb; 18(2):127-33. PubMed ID: 16781857
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diet and exercise reduce pre-existing NASH and fibrosis and have additional beneficial effects on the vasculature, adipose tissue and skeletal muscle via organ-crosstalk.
    van den Hoek AM; de Jong JCBC; Worms N; van Nieuwkoop A; Voskuilen M; Menke AL; Lek S; Caspers MPM; Verschuren L; Kleemann R
    Metabolism; 2021 Nov; 124():154873. PubMed ID: 34478753
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cannabinoid receptor type 2 (CB2) deficiency alters atherosclerotic lesion formation in hyperlipidemic Ldlr-null mice.
    Netherland CD; Pickle TG; Bales A; Thewke DP
    Atherosclerosis; 2010 Nov; 213(1):102-8. PubMed ID: 20846652
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of K-877, a novel selective PPARα modulator, on small intestine contribute to the amelioration of hyperlipidemia in low-density lipoprotein receptor knockout mice.
    Takei K; Nakagawa Y; Wang Y; Han SI; Satoh A; Sekiya M; Matsuzaka T; Shimano H
    J Pharmacol Sci; 2017 Apr; 133(4):214-222. PubMed ID: 28366492
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Increased inflammation in atherosclerotic lesions of diabetic Akita-LDLr⁻/⁻ mice compared to nondiabetic LDLr⁻/⁻ mice.
    Engelbertsen D; To F; Dunér P; Kotova O; Söderberg I; Alm R; Gomez MF; Nilsson J; Bengtsson E
    Exp Diabetes Res; 2012; 2012():176162. PubMed ID: 23243415
    [TBL] [Abstract][Full Text] [Related]  

  • 53. SGLT2 inhibition reduces atherosclerosis by enhancing lipoprotein clearance in Ldlr
    Al-Sharea A; Murphy AJ; Huggins LA; Hu Y; Goldberg IJ; Nagareddy PR
    Atherosclerosis; 2018 Apr; 271():166-176. PubMed ID: 29518749
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Low-Density Lipoprotein Receptor-Dependent and Low-Density Lipoprotein Receptor-Independent Mechanisms of Cyclosporin A-Induced Dyslipidemia.
    Kockx M; Glaros E; Leung B; Ng TW; Berbée JF; Deswaerte V; Nawara D; Quinn C; Rye KA; Jessup W; Rensen PC; Meikle PJ; Kritharides L
    Arterioscler Thromb Vasc Biol; 2016 Jul; 36(7):1338-49. PubMed ID: 27150391
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison between genetic and pharmaceutical disruption of Ldlr expression for the development of atherosclerosis.
    Gomes D; Wang S; Goodspeed L; Turk KE; Wietecha T; Liu Y; Bornfeldt KE; O'Brien KD; Chait A; den Hartigh LJ
    J Lipid Res; 2022 Mar; 63(3):100174. PubMed ID: 35101425
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prevention of Diet-Induced Metabolic Dysregulation, Inflammation, and Atherosclerosis in
    Samsoondar JP; Burke AC; Sutherland BG; Telford DE; Sawyez CG; Edwards JY; Pinkosky SL; Newton RS; Huff MW
    Arterioscler Thromb Vasc Biol; 2017 Apr; 37(4):647-656. PubMed ID: 28153881
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effects of diet on occlusive coronary artery atherosclerosis and myocardial infarction in scavenger receptor class B, type 1/low-density lipoprotein receptor double knockout mice.
    Fuller M; Dadoo O; Serkis V; Abutouk D; MacDonald M; Dhingani N; Macri J; Igdoura SA; Trigatti BL
    Arterioscler Thromb Vasc Biol; 2014 Nov; 34(11):2394-403. PubMed ID: 25212235
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Genetic disruption of myostatin reduces the development of proatherogenic dyslipidemia and atherogenic lesions in Ldlr null mice.
    Tu P; Bhasin S; Hruz PW; Herbst KL; Castellani LW; Hua N; Hamilton JA; Guo W
    Diabetes; 2009 Aug; 58(8):1739-48. PubMed ID: 19509018
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Therapeutic silencing of FSP27 reduces the progression of atherosclerosis in Ldlr
    Rajamoorthi A; Lee RG; Baldán Á
    Atherosclerosis; 2018 Aug; 275():43-49. PubMed ID: 29859472
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Expressions of atherosclerosis-related genes in aorta in young apoE/LDLR double knockout mice].
    Dai XD; Yin M; Jing W; DU HQ; Ye HY; Shang YJ; Zhang L; Zou YY; Qu ZP; Pan J
    Sheng Li Xue Bao; 2008 Feb; 60(1):43-50. PubMed ID: 18288357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.